Skip to main content

Advertisement

Table 1 Demographic and clinical characteristics of the study population *, †

From: Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects

Characteristics Men Women
  Control (n = 562) CAD (n = 693) Control (n = 443) CAD (n = 360)
Age, yrs ‡, § 58.1 ± 14.6 63.7 ± 11.4 || 61.4 ± 12.5 68.1 ± 10.2 ||
BMI, kg/m2 24.3 ± 4.32 24.7 ± 4.01 24.2 ± 4.33 24.6 ± 3.41
Smokers ‡, § 186(33.1%) 253(36.5%) || 7(1.6%) 10(2.8%)
Hypertension ‡, § 315(56.0%) 421(60.8%) 269(60.7%) 255(70.8%) ||
Positive family history 44(7.8%) 31(4.5%) 30(6.8%) 30(8.3%)
Total cholesterol, mmol/L ‡, § 4.63 ± 1.03 4.57 ± 1.03 4.91 ± 1.06 5.08 ± 1.09 ||
Triglycerides, mmol/L 1.82 ± 1.24 1.93 ± 1.27 || 1.74 ± 1.13 1.95 ± 1.19 ||
LDL cholesterol, mmol/L § 2.95 ± 0.90 2.92 ± 0.94 3.04 ± 0.94 3.16 ± 0.97
HDL cholesterol, mmol/L ‡, § 1.06 ± 0.29 1.03 ± 0.34 || 1.22 ± 0.30 1.18 ± 0.29 ||
ApoA-I, mg/L 1.18 ± 0.44 1.11 ± 0.32 || 1.31 ± 0.46 1.25 ± 0.26 ||
ApoB, mg/L 0.77(0.64-0.88) 0.76(0.61-0.89) 0.78(0.64-0.90) 0.80(0.65-0.97)
LpA, mg/L 0.32(0.25-0.44) 0.34(0.24-0.47) 0.33(0.26-0.41) 0.34(0.26-0.45)
LDL cholesterol/ApoB ratio 3.87(3.46-4.23) 3.81(3.42-4.21) 3.88(3.45-4.29) 3.82(3.51-4.21)
Fasting plasma glucose, mmol/L 5.80 ± 2.23 6.19 ± 2.43 || 5.98 ± 2.45 6.32 ± 2.81 ||
Creatinine, μmol/L 87.5(73.0-104) 89.0(76.0-104) || 69.0(56.0-85.0) 71.0(58.0-89.0) ||
tHcy, μmol/L ‡, § 13.8 ± 5.93 14.5 ± 6.13 || 12.3 ± 5.53 12.9 ± 6.08 ||
tCys, μmol/L 248.4 ± 46.3 255.8 ± 48.3 || 254.2 ± 47.6 251.3 ± 45.5
  1. * Values are mean ± SD, n (%), or median (interquartile range)
  2. † BMI and plasma variables in the four groups were compared by Kruskal-Wallis test followed where relevant by Mann-Whitney U test with adjustment for multiple comparisons. P < 0.0125(0.05/4) was considered significant.
  3. ‡ Significantly different in men compared to women in the no CAD group.
  4. § Significantly different in men compared to women in the CAD group.
  5. || Significantly different compared to no CAD group within the same gender.